 MILAN, Italy and NEW YORK, May 13, 2022 GLOBE NEWSWIRE -- Genenta Science NASDAQ: GNTA, a clinical-stage biotechnology company pioneering the development of hematopoietic stem progenitor cell immuno-gene therapy for cancer, will be presenting at several upcoming scientific congresses in May and June. 